載入...
Safety and tolerability of intravenous regadenoson in healthy subjects: A randomized, repeat-dose, placebo-controlled study
BACKGROUND: Regadenoson is a selective A(2A) adenosine receptor agonist indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. However, the safety, tolerability, and plasma concentrations associated with repeated doses have not previously been...
Na minha lista:
| 發表在: | J Nucl Cardiol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer US
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5250646/ https://ncbi.nlm.nih.gov/pubmed/26607361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12350-015-0327-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|